TNFSF11 and breast carcinoma: It begins when metastatic breast cancer cells produce parathyroid hormone-releasing peptide (PTHrP), which binds to the same receptors as parathyroid hormone and stimulates osteoblasts to secrete increased amounts of RANK-L.